Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of the registrant’s common stock outstanding as of ~~February 3,~~May 7, 2010 was ~~29,059,664.~~29,084,386.


							Fiscal Quarter Ended						Six Months Ended
	Fiscal Quarter Ended						April 2,			April 3,			April 2,			April 3,
	January 1, 2010			January 2, 2009			2010			2009			2010			2009
Sales
Products	$	166,587		$	175,854		$	176,269		$	172,613		$	342,856		$	348,467
Services		34,593			32,382			35,586			32,813			70,179			65,195

Total sales		201,180			208,236			211,855			205,426			413,035			413,662

Cost of sales
Products		94,588			94,523			101,332			97,436			195,920			191,959
Services		19,715			18,392			21,155			18,466			40,870			36,858

Total cost of sales		114,303			112,915			122,487			115,902			236,790			228,817

Gross profit		86,877			95,321			89,368			89,524			176,245			184,845

Operating expenses
Selling, general and administrative		59,877			60,916			59,752			59,278			119,629			120,194
Research and development		14,546			14,514			14,999			14,745			29,545			29,259

Total operating expenses		74,423			75,430			74,751			74,023			149,174			149,453

Operating earnings		12,454			19,891			14,617			15,501			27,071			35,392
Interest income		530			587			920			338			1,450			925
Interest expense		(333	)		(322	)		(325	)		(335	)		(658	)		(657	)

Earnings before income taxes		12,651			20,156			15,212			15,504			27,863			35,660
Income tax expense		4,580			7,115			5,537			5,318			10,117			12,433

Net earnings	$	8,071		$	13,041		$	9,675		$	10,186		$	17,746		$	23,227


Net earnings per share:
Basic	$	0.28		$	0.45		$	0.33		$	0.35		$	0.61		$	0.81

Diluted	$	0.28		$	0.45		$	0.33		$	0.35		$	0.61		$	0.80

Shares used in per share calculation:
Basic		28,863			28,854			28,940			28,853			28,902			28,853

Diluted		29,246			28,950			29,303			28,952			29,263			28,963

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.


					April 2, 2010		October 2, 2009
	January 1, 2010		October 2, 2009		April 2, 2010		October 2, 2009
ASSETS
Current assets
Cash and cash equivalents	$	229,307	$	209,348	$	232,271	$	209,348
Accounts receivable, net		147,633		159,958		155,867		159,958
Inventories		135,145		136,704		131,932		136,704
Deferred taxes		38,461		38,349		38,715		38,349
Prepaid expenses and other current assets		13,366		15,488		15,125		15,488

Total current assets		563,912		559,847		573,910		559,847
Property, plant and equipment, net		110,396		114,363		104,469		114,363
Goodwill		215,593		216,223		211,426		216,223
Intangible assets, net		26,560		28,334		24,088		28,334
Other assets		26,993		25,420		26,447		25,420

Total assets	$	943,454	$	944,187	$	940,340	$	944,187

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities
Current portion of long-term debt	$	6,250	$	6,250	$	6,250	$	6,250
Accounts payable		56,702		63,368		55,620		63,368
Deferred profit		10,561		8,935		8,019		8,935
Accrued liabilities		163,839		171,103		163,545		171,103

Total current liabilities		237,352		249,656		233,434		249,656
Long-term debt		12,500		12,500		12,500		12,500
Deferred taxes		2,718		2,505
Deferred taxes.						2,541		2,505
Other liabilities		42,980		41,255		41,935		41,255

Total liabilities		295,550		305,916		290,410		305,916

Commitments and contingencies (Notes 2, 6, 7, 9, 10, 11, 12 and 13)

Stockholders’ equity
Preferred stock—par value $0.01, authorized—1,000 shares; issued—none		—		—
Common stock—par value $0.01, authorized—99,000 shares; issued and outstanding—29,026 shares at January 1, 2010 and 28,971 shares at October 2, 2009		371,685		368,324
Common stock—par value $0.01, authorized—99,000 shares; issued and outstanding—29,079 shares at April 2, 2010 and 28,971 shares at October 2, 2009						375,376		368,324
Retained earnings		228,040		220,068		237,169		220,068
Accumulated other comprehensive income		48,179		49,879		37,385		49,879

Total stockholders’ equity		647,904		638,271		649,930		638,271

Total liabilities and stockholders’ equity	$	943,454	$	944,187	$	940,340	$	944,187

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.


							Six Months Ended
	Fiscal Quarter Ended						April 2, 2010			April 3, 2009
	January 1, 2010			January 2, 2009			April 2, 2010			April 3, 2009
Cash flows from operating activities
Net earnings	$	8,071		$	13,041		$	17,746		$	23,227
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization		6,867			6,843			13,211			13,371
Loss (gain) on disposition of property, plant and equipment		34			(27	)		13			(4	)
Share-based compensation expense		1,232			2,366			2,073			4,311
Deferred taxes		408			113			896			(655	)
Unrealized loss (gain) on currency remeasurement		1,449			(6,686	)		1,923			(6,363	)
Changes in assets and liabilities, excluding effects of acquisitions:
Accounts receivable, net		11,505			24,570			(77	)		32,119
Inventories		595			(7,942	)		1,147			1,182
Prepaid expenses and other current assets		2,144			(107	)		171			229
Other assets		(1,671	)		(1,029	)		(1,628	)		(1,148	)
Accounts payable		(5,981	)		(3,618	)		(6,006	)		(9,394	)
Deferred profit		1,651			303			(721	)		1,548
Accrued liabilities		(5,364	)		(15,619	)		(3,337	)		(6,900	)
Other liabilities		1,791			4,723			1,122			(1,013	)

Net cash provided by operating activities		22,731			16,931			26,533			50,510

Cash flows from investing activities
Proceeds from sale of property, plant and equipment		72			5,166			101			5,246
Purchase of property, plant and equipment		(2,054	)		(6,943	)		(2,381	)		(15,137	)
Purchase of businesses, net of cash acquired		(1,455	)		(726	)
Acquisitions, net of cash acquired								(1,918	)		(2,247	)

Net cash used in investing activities		(3,437	)		(2,503	)		(4,198	)		(12,138	)

Cash flows from financing activities
Repurchase of common stock		(215	)		(279	)		(864	)		(7,475	)
Issuance of common stock		2,066			909			4,553			2,315
Transfers to Varian Medical Systems, Inc.		(210	)		(146	)		(409	)		(365	)

Net cash provided by financing activities		1,641			484
Net cash provided by (used in) financing activities								3,280			(5,525	)

Effects of exchange rate changes on cash and cash equivalents		(976	)		(1,878	)		(2,692	)		(6,237	)

Net increase in cash and cash equivalents		19,959			13,034			22,923			26,610
Cash and cash equivalents at beginning of period		209,348			103,895			209,348			103,895

Cash and cash equivalents at end of period	$	229,307		$	116,929		$	232,271		$	130,505

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

These unaudited interim condensed consolidated financial statements of Varian, Inc. and its subsidiary companies (collectively, the “Company”) have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The October 2, 2009 balance sheet data was derived from audited financial statements, but does not include all disclosures required in audited financial statements by U.S. GAAP. These unaudited interim condensed consolidated financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended October 2, 2009 filed with the SEC. In the opinion of the Company’s management, the unaudited interim condensed consolidated financial statements include all normal recurring adjustments necessary to present fairly the information required to be set forth therein. The results of operations for the ~~fiscal quarter~~six months ended ~~January 1,~~April 2, 2010 are not necessarily indicative of the results to be expected for a full year or for any other periods.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

The Company designs, develops, manufactures, markets, sells and services scientific instruments (including analytical instruments, research products and related software, consumable products, accessories and services) and vacuum products (including related accessories and services). These businesses primarily serve life science, environmental, energy, and applied research and other customers.

Until April 2, 1999, the business of the Company was operated as the Instruments Business of Varian Associates, Inc. (“VAI”). On that date, VAI distributed to the holders of its common stock one share of common stock of the Company and one share of common stock of Varian Semiconductor Equipment Associates, Inc. (“VSEA”), which was formerly operated as the Semiconductor Equipment business of VAI, for each share of VAI (the “Distribution”). VAI retained its Health Care Systems business and changed its name to Varian Medical Systems, Inc. (“VMS”). Transfers made to VMS under the terms of the Distribution are reflected as financing activities in the Unaudited Condensed Consolidated Statement of Cash Flows.

Merger Agreement.On July 26, 2009, the Company, Agilent Technologies, Inc., a Delaware corporation (“Agilent”), and Cobalt Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Agilent (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Merger Sub will, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, merge with and into the Company and the Company will survive the merger and continue as a wholly owned subsidiary of Agilent (the “Merger”). Pursuant to the terms of the Merger Agreement and subject to the conditions thereof, at the effective time of the Merger (the “Effective Time”), each share of common stock of the Company issued and outstanding immediately prior to the Effective Time will be converted into the right to receive $52.00 in cash, without interest.

The Company and Agilent have made certain representations, warranties and covenants in the Merger Agreement, including, among others, covenants that, subject to certain exceptions, (i) the Company will conduct

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

its business in the ordinary course consistent with past practice, and refrain from taking specified actions, during the period between the execution of the Merger Agreement and the Effective Time, (ii) the Board of Directors of the Company will recommend to its stockholders adoption of the Merger Agreement, and (iii) the Company will not solicit, initiate, seek or knowingly encourage or facilitate, any inquiry, proposal or offer from, furnish non-public information to, or participate in any discussions with, or enter into any agreement with, any person or group regarding any alternative transaction.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Merger Agreement contains certain termination rights for both the Company and Agilent and further provides that, upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Agilent a termination fee of $46 million.

The Boards of Directors of the Company and Agilent approved the Merger and the Merger Agreement. In addition, concurrently with the execution of the Merger Agreement, all directors and certain executive officers of the Company, who together held less than 1% of the Company’s outstanding common stock as of July 26, 2009, entered into voting agreements whereby they agreed among other things to vote all shares of the Company’s common stock held by them in favor of the adoption of the Merger Agreement.

On October 5, 2009, the Company’s stockholders approved the Merger. The Merger remains subject to regulatory approvals and the satisfaction or waiver of certain other closing conditions.

Fiscal Periods. The Company’s fiscal years reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2010 will comprise the 52-week period ending October 1, 2010, and fiscal year 2009 was comprised of the 52-week period ended October 2, 2009. The fiscal quarters and six months ended ~~January 1,~~April 2, 2010 and ~~January 2,~~April 3, 2009 each comprised 13 ~~weeks.~~weeks and 26 weeks, respectively.

~~Subsequent Events.~~ ~~In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 855,~~~~Subsequent Events~~~~, the Company has evaluated subsequent events through the time the Company’s Unaudited Condensed Consolidated Financial Statements were issued on February 5, 2010.~~

A summary of the components of the Company’s comprehensive (loss) income ~~(loss)~~ follows:


							Fiscal Quarter Ended						Six Months Ended
	Fiscal Quarter Ended						April 2, 2010			April 3, 2009			April 2, 2010			April 3, 2009
	January 1, 2010			January 2, 2009			April 2, 2010						April 2, 2010			April 3, 2009
(in thousands)										April 3, 2009
Net earnings	$	8,071		$	13,041		$	9,675		$	10,186		$	17,746		$	23,227
Other comprehensive loss:
Currency translation adjustment		(1,700	)		(32,569	)		(10,793	)		(13,684	)		(12,493	)		(46,253	)
Reduction in minimum liability due to curtailment of defined benefit pension plan, net of tax of ($854)								—			2,196			—			2,196

Total other comprehensive loss		(1,700	)		(32,569	)		(10,793	)		(11,488	)		(12,493	)		(44,057	)

Total comprehensive income (loss)	$	6,371		$	(19,528	)
Total comprehensive (loss) income							$	(1,118	)	$	(1,302	)	$	5,253		$	(20,830	)

Effective October 3, 2009 (the first day of fiscal year 2010), the Company adopted ASC 820,Fair Value Measurements and Disclosures, for certain non-recurring nonfinancial assets and nonfinancial liabilities.

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

Fair Value Hierarchy.ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are:

Level 1—Observable inputs that reflect quoted prices for identical assets or liabilities in active markets.

Level 2—Other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs which are supported by little or no market activity.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Financial assets measured at fair value on a recurring basis as of ~~January 1,~~April 2, 2010 follow:


	Fair Value Measurements Using:								Fair Value Measurements Using:
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in thousands)
Financial assets:
Money market funds (cash equivalents)	$	59,283	$	—	$	—	$	59,283	$	60,876	$	—	$	—	$	60,876

Total financial assets	$	59,283	$	—	$	—	$	59,283	$	60,876	$	—	$	—	$	60,876

The cost basis of cash and cash equivalents approximates fair value due to the short period of time to maturity.


							April 2, 2010			October 2, 2009
	January 1, 2010			October 2, 2009			April 2, 2010			October 2, 2009
(in thousands)
Inventories
Raw materials and parts	$	60,644		$	60,222		$	59,291		$	60,222
Work in process		22,998			22,596			24,115			22,596
Finished goods		51,503			53,886			48,526			53,886

Total	$	135,145		$	136,704		$	131,932		$	136,704


Deferred profit
Revenue	$	23,808		$	20,601		$	20,162		$	20,601

Cost of sales	$	(13,247	)	$	(11,666	)	$	(12,143	)	$	(11,666	)

The Company enters into foreign exchange forward contracts to minimize the short-term impact of foreign currency fluctuations on the Company’s legal entities’ monetary assets and liabilities denominated in currencies other than their functional currencies. These foreign currency exposures mainly arise from intercompany transactions by and between the parent company and its various foreign subsidiaries. The Company does not designate its forward exchange contracts as hedging instruments, and these contracts do not qualify for hedge accounting treatment.

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

The Company’s forward exchange contracts generally have maturities of one month or less and are closed out and rolled over into new contracts at the end of each monthly reporting period. Consequently, the fair value of these contracts has historically not been significant at the end of each reporting period.Typically, realized gains and losses on forward exchange contracts, which arise as a result of closing out the contracts at the end of each reporting period, are substantially offset by revaluation losses and gains on the underlying balances denominated in non-functional currencies. However, an inaccurate forecast of foreign currency assets or liabilities, coupled with a currency movement, would result in a gain or loss on a net basis. Gains and losses on forward exchange contracts and from revaluation of the underlying asset and liability balances denominated in non-functional currencies are recognized in the Unaudited Condensed Consolidated Statement of Earnings in selling, general and administrative expenses.

During the fiscal ~~quarters~~quarter and six months ended ~~January 1,~~April 2, 2010, the Company recognized a net foreign currency loss of $0.2 million and ~~January 2,~~a net foreign currency gain of $0.5 million, respectively. During the fiscal quarter and six months ended April 3, 2009, the Company recognized a net foreign currency ~~gains~~gain of ~~$0.7~~$0.2 million and ~~losses~~a net foreign currency loss of ~~$1.1~~$0.9 million, respectively.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Other than foreign exchange forward contracts, the Company has no other freestanding or embedded derivative instruments, although the Company may use other derivative instruments in the future. The Company has not entered into forward exchange contracts for speculative or trading purposes.

As of ~~January 1,~~April 2, 2010, the Company had foreign exchange forward contracts to purchase the U.S. dollar equivalent of ~~$58.3~~$61.4 million and to sell the U.S. dollar equivalent of ~~$12.8~~$19.6 million in various foreign currencies.

Effective October 3, 2009 (the first day of fiscal year 2010), the Company adopted revised accounting standards for business combinations. These revised standards generally require an entity to recognize the assets acquired, liabilities assumed, contingencies and contingent consideration at their fair value on the acquisition date. The ~~adoption of the revised standards had no financial impact on the Company’s financial condition or results of operations. The~~ new guidance is only applicable to acquisitions completed after the adoption date with the exception of certain tax contingencies and adjustments to valuation allowances, which previously were adjusted to goodwill but must now be adjusted to income tax expense regardless of the date of the original acquisition. The adoption of the revised standards had no financial impact on the Company’s financial condition or results of operations.

Contingent Consideration Arrangements. The Company is, from time to time, obligated to pay additional cash purchase price amounts in the event that certain financial or operational milestones are met by acquired businesses. As of ~~January 1,~~April 2, 2010, up to a maximum of ~~$10.1~~$6.3 million could be payable through April 2011 under contingent consideration arrangements relating to acquired businesses. Amounts subject to these arrangements can be earned over ~~the~~their respective measurement ~~period,~~periods, depending on the performance of the acquired business relative to certain financial and/or operational targets.

The following table summarizes contingent consideration arrangements as of ~~January 1,~~April 2, 2010:

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

During the first quarter of fiscal year 2010, the Company made a cash payment of $1.3 million which was accrued as part of the purchase price to secure the seller’s indemnification obligations in connection with the acquisition of the Analogix Business in fiscal year 2007.

Changes in the carrying amount of goodwill for each of the Company’s reporting segments in the first ~~quarter~~six months of fiscal year 2010 were as follows:


									Scientific Instruments			Vacuum Technologies		Total Company
	Scientific Instruments			Vacuum Technologies		Total Company			Scientific Instruments			Vacuum Technologies		Total Company
(in thousands)
Balance as of October 2, 2009	$	215,257		$	966	$	216,223		$	215,257		$	966	$	216,223
Contingent payments on prior-year acquisitions		131			—		131			599			—		599
Foreign currency impacts and other adjustments		(761	)		—		(761	)		(5,396	)		—		(5,396	)

Balance as of January 1, 2010	$	214,627		$	966	$	215,593
Balance as of April 2, 2010									$	210,460		$	966	$	211,426

~~The following intangible assets have been recorded~~As required by ASC 350-20-35-28,Intangibles - Goodwill and ~~are being amortized by~~Other, the ~~Company:~~Company performs an annual goodwill impairment assessment. This assessment is performed in the second quarter of each fiscal year. During the fiscal quarter ended April 2, 2010, the Company completed its annual impairment test and determined that there was no impairment of goodwill.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following intangible assets have been recorded and are being amortized by the Company:

Amortization expense relating to intangible assets was $1.8 million and ~~$2.1~~$3.6 million during the fiscal ~~quarters~~quarter and six months ended ~~January 1,~~April 2, 2010, respectively. Amortization expense relating to intangible assets was $1.8 million and ~~January 2,~~$3.9 million during the fiscal quarter and six months ended April 3, 2009, respectively. At ~~January 1,~~April 2, 2010, estimated amortization expense for the remainder of fiscal year 2010 and for each of the five succeeding fiscal years and thereafter follows:


(in thousands)
Estimated amortization expense
Nine months ending October 1, 2010	$	5,413
Six months ending October 1, 2010			$	3,462
Fiscal year 2011		5,020		4,909
Fiscal year 2012		4,063		3,960
Fiscal year 2013		3,536		3,445
Fiscal year 2014		3,368		3,283
Fiscal year 2015		3,264		3,181
Thereafter		1,896		1,848

Total	$	26,560	$	24,088

Summary of Restructuring Plans.The Company has committed to several restructuring plans in order to improve operational efficiencies, centralize functions, reallocate resources and reduce operating costs.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table sets forth changes in the Company’s aggregate restructuring liability relating to all ongoing restructuring plans during the first ~~quarter~~and second quarters of fiscal year 2010 as well as total restructuring expense and other related costs recorded since the inception of those plans:

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

Product Warranties. The Company’s products are generally subject to warranties. Liabilities for the estimated future costs of repair or replacement are established and charged to cost of sales at the time the related sale is recognized. The amount of liability to be recorded is based on management’s best estimates of future warranty costs after considering historical and projected product failure rates and product repair costs.

Changes in the Company’s estimated liability for product warranty during the ~~fiscal quarters~~six months ended ~~January 1,~~April 2, 2010 and ~~January 2,~~April 3, 2009 follow:


							Six Months Ended
	Fiscal Quarter Ended						April 2, 2010			April 3, 2009
	January 1, 2010			January 2, 2009			April 2, 2010			April 3, 2009
(in thousands)
Beginning balance	$	13,273		$	13,867		$	13,273		$	13,867
Charges to costs and expenses		4,864			5,037			10,194			10,876
Warranty expenditures and other adjustments		(4,889	)		(5,720	)		(10,399	)		(11,429	)

Ending balance	$	13,248		$	13,184		$	13,068		$	13,314

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Indemnification Obligations. ASC 460,Guarantees, requires a guarantor to recognize a liability for and/or disclose obligations it has undertaken in relation to the issuance of the guarantee. Under this guidance, arrangements involving indemnification clauses are subject to the disclosure requirements of ASC 460 only.

The Company is subject to certain indemnification obligations to VMS (formerly VAI) and VSEA in connection with the Instruments business as conducted by VAI prior to the Distribution (described in Note 2). These indemnification obligations cover a variety of aspects of the Company’s business, including, but not limited to, employee, tax, intellectual property, litigation and environmental matters. Certain of the agreements containing these indemnification obligations are disclosed as exhibits to the Company’s Annual Report on Form 10-K. The estimated fair value of these indemnification obligations is not considered to be material.

The Company is subject to certain indemnification obligations to Jabil Circuit, Inc. (“Jabil”) in connection with the Company’s sale of its Electronics Manufacturing Business to Jabil. These indemnification obligations cover certain aspects of the Company’s conduct of the Electronics Manufacturing Business prior to its sale to Jabil, including, but not limited to, employee, tax, litigation and environmental matters. The agreement containing these indemnification obligations is disclosed as an exhibit to the Company’s Annual Report on Form 10-K. The estimated fair value of these indemnification obligations is not considered to be material.

The Company’s By-Laws require it to indemnify its officers and directors, as well as those who act as directors and officers of other entities at the request of the Company, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to the Company. In addition, the Company has entered into separate indemnity agreements with each director and officer that provide for indemnification of these directors and officers under certain circumstances. The form of these indemnity agreements is disclosed as an exhibit to the Company’s Annual Report on Form 10-K. The indemnification obligations are more fully described in these indemnity agreements and the Company’s By-Laws. The Company purchases insurance to cover claims or a portion of any claims made against its directors and officers. Since a maximum obligation is not explicitly stated in the Company’s By-Laws or these indemnity agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot reasonably be estimated. Historically, the Company has

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

not made payments related to these indemnification obligations and the estimated fair value of these indemnification obligations is not considered to be material.

As is customary in the Company’s industry and as provided for in local law in the U.S. and other jurisdictions, many of the Company’s standard contracts provide remedies to customers and other third parties with whom the Company enters into contracts, such as defense, settlement or payment of judgment for intellectual property claims related to the use of its products. From time to time, the Company also agrees to indemnify customers, suppliers, contractors, lessors, lessees and others with whom it enters into contracts, against loss, expense and/or liability arising from various triggering events related to the sale and the use of the Company’s products and services, the use of their goods and services, the use of facilities and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time, the Company sometimes also agrees to indemnify these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. Claims made under such indemnification obligations have been insignificant and the estimated fair value of these indemnification obligations is not considered to be material.

Credit Facilities. The Company maintains relationships with banks in many countries from whom it sometimes obtains bank guarantees and short-term standby letters of credit. These guarantees and letters of credit relate primarily to advance payments and deposits made to the Company’s subsidiaries by customers for which separate liabilities are recorded in the unaudited condensed consolidated financial statements. As of ~~January 1,~~April 2, 2010, a total of ~~$13.8~~$12.2 million of these bank guarantees and letters of credit were outstanding. No amounts had been drawn by beneficiaries under these or any other outstanding guarantees or letters of credit as of that date.

Long-term Debt. As of both ~~January 1,~~April 2, 2010 and October 2, 2009, the Company had an $18.8 million term loan outstanding with a U.S. financial institution at a fixed interest rate of 6.7%. The term loan contains certain covenants that limit future borrowings and the payment of cash dividends and require the maintenance of certain levels of working capital and operating results. The Company was in compliance with all restrictive covenants of the term loan agreement at ~~January 1,~~April 2, 2010.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes future principal payments on borrowings under long-term debt outstanding as of ~~January 1,~~April 2, 2010:


	Nine Months Ending Oct. 1, 2010			Fiscal Years																					Six Months Ending Oct. 1,			Fiscal Years
			2011			2012			2013			2014			2015			Thereafter			Total			2010			2011			2012			2013			2014			2015			Thereafter			Total
(in thousands)
Long-term debt
(including current portion)	$	6,250		$	—		$	6,250		$	—		$	6,250		$	—		$	—		$	18,750		$	6,250		$	—		$	6,250		$	—		$	6,250		$	—		$	—		$	18,750

Based upon rates currently available to the Company for debt with similar terms and remaining maturities, the carrying amount of long-term debt approximates the estimated fair value.

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

Net Periodic Pension Cost. The components of net periodic pension cost relating to the Company’s defined benefit retirement plans follow:


	Fiscal Quarter Ended
	January 1,			January 2,			Fiscal Quarter Ended						Six Months Ended
	2010			2009			April 2, 2010			April 3, 2009			April 2, 2010			April 3, 2009
(in thousands)
Service cost	$	133		$	249		$	133		$	249		$	266		$	498
Interest cost		679			705			679			705			1,358			1,410
Expected return on plan assets		(511	)		(570	)		(511	)		(570	)		(1,022	)		(1,140	)
Amortization of prior service cost and actuarial gains and losses		(1	)		17			(1	)		17			(2	)		34
Curtailment loss recognized								—			135			—			135

Net periodic pension cost	$	300		$	401		$	300		$	536		$	600		$	937

Employer Contributions. During the fiscal quarter and six months ended ~~January 1,~~April 2, 2010, the Company made contributions totaling approximately $0.1 million and $0.2 million to its defined benefit pension plans. The Company currently anticipates contributing an additional ~~$0.2~~$0.1 million to these plans in the remaining ~~nine~~six months of fiscal year 2010.

Environmental Matters. The Company’s operations are subject to various federal, state and local laws in the U.S. as well as laws in other countries regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. These regulations increase the costs and potential liabilities of the Company’s operations. However, the Company does not currently anticipate that its compliance with these regulations will have a material effect on the Company’s capital expenditures, earnings or competitive position.

The Company and VSEA are each obligated (under the terms of the Distribution described in Note 2) to indemnify VMS for one-third of certain costs (after adjusting for any insurance recoveries and tax benefits recognized or realized by VMS for such costs) relating to (a) environmental investigation, monitoring and/or remediation activities at certain facilities previously operated by VAI and third-party claims made in connection with environmental conditions at those facilities, and (b) U.S. Environmental Protection Agency or third-party claims alleging that VAI or VMS is a potentially responsible party under the Comprehensive Environmental Response Compensation and Liability Act of 1980, as amended (“CERCLA”) in connection with certain sites to which VAI allegedly shipped manufacturing waste for recycling, treatment or disposal (the “CERCLA sites”). With respect to the facilities formerly operated by VAI, VMS is overseeing the environmental investigation, monitoring and/or remediation activities, in most cases under the direction of or in consultation with federal, state and/or local agencies, and handling third-party claims. VMS is also handling claims relating to the CERCLA sites.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Various uncertainties make it difficult to estimate future costs for certain of these environmental-related activities, specifically external legal expenses, VMS’ internal oversight costs, third-party claims and a former VAI facility where the likelihood and scope of further environmental-related activities are difficult to assess. As of ~~January 1,~~April 2, 2010, it was nonetheless estimated that the Company’s future exposure for these environmental-related costs ranged in the aggregate from $1.0 million to $2.5 million. The time frame over which these costs are expected to be incurred varies with each type of cost, ranging up to approximately 30 years as of ~~January 1,~~April 2, 2010. No amount in the foregoing range of estimated future costs is discounted, and no amount in the range is believed to be more probable of being incurred than any other amount in such range. The Company therefore had an accrual of $1.0 million as of ~~January 1,~~April 2, 2010 for these future environmental-related costs.

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

Sufficient knowledge has been gained to be able to better estimate other costs for future environmental-related activities. As of ~~January 1,~~April 2, 2010, it was estimated that the Company’s future costs for these environmental-related activities ranged in the aggregate from $2.5 million to ~~$12.7~~$12.6 million. The time frame over which these costs are expected to be incurred varies, ranging up to approximately 30 years as of ~~January 1,~~April 2, 2010. As to each of these ranges of cost estimates, it was determined that a particular amount within the range was a better estimate than any other amount within the range. Together, these amounts totaled ~~$5.5~~$5.4 million at ~~January 1,~~April 2, 2010. Because both the amount and timing of the recurring portion of these costs were reliably determinable, that portion is discounted at 4%, net of inflation. The Company therefore had an accrual of $4.0 million as of ~~January 1,~~April 2, 2010, which represents its best estimate of these future environmental-related costs after discounting estimated recurring future costs. This accrual is in addition to the $1.0 million described in the preceding paragraph.

The Company has not reduced any environmental-related liability in anticipation of recoveries from third parties. However, an insurance company has agreed to pay a portion of certain of VAI’s (now VMS’) future environmental-related costs, for which the Company has an indemnification obligation, and the Company therefore has a long-term receivable of $1.0 million (discounted at 4%, net of inflation) in Other assets as of ~~January 1,~~April 2, 2010, for the Company’s share of that insurance recovery.

The Company believes that its reserves for the foregoing and other environmental-related matters are adequate, but as the scope of its obligation becomes more clearly defined, these reserves may be modified and related charges against or credits to earnings may be made. Although any ultimate liability arising from environmental-related matters could result in significant expenditures that, if aggregated and assumed to occur within a single fiscal year, would be material to the Company’s financial statements, the likelihood of such occurrence is considered remote. Based on information currently available and its best assessment of the ultimate amount and timing of environmental-related events, the Company believes that the costs of ~~environmental- related~~environmental-related matters are not reasonably likely to have a material adverse effect on the Company’s financial condition or results of operations.

Legal Proceedings. The Company is involved in pending legal proceedings that are ordinary, routine and incidental to its business. While the ultimate outcome of these legal matters is not determinable, the Company believes that these matters are not reasonably likely to have a material adverse effect on the Company’s financial condition or results of operations.

Share-Based Compensation Expense. The following table summarizes the amount of share-based compensation expense by award type as well as the effect of this expense on income tax expense and net earnings:


							Fiscal Quarter Ended						Six Months Ended
	Fiscal Quarter Ended						April 2,			April 3,			April 2,			April 3,
	January 1, 2010			January 2, 2009			2010			2009			2010			2009
(in thousands)
Share-based compensation expense by award type:
Employee and non-employee director stock options	$	799		$	1,365		$	459		$	1,272		$	1,258		$	2,637
Employee stock purchase plan		—			336			—			158			—			494
Restricted (nonvested) stock		433			665			382			290			815			955
Non-employee director stock units								—			225			—			225

Total share-based compensation expense (effect on earnings before income taxes)		1,232			2,366			841			1,945			2,073			4,311
Effect on income tax expense		(430	)		(773	)		(294	)		(694	)		(724	)		(1,467	)

Effect on net earnings	$	802		$	1,593		$	547		$	1,251		$	1,349		$	2,844

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Share-based compensation expense in the preceding table related to restricted (nonvested) stock includes $35,000 and $70,000 in the fiscal quarter and six months ended ~~January 1,~~April 2, 2010, respectively, and ~~$104,000~~$49,000 and $154,000 in the fiscal quarter and six months ended ~~January 2,~~April 3, 2009, respectively, related to restricted stock granted in connection with the Company’s fiscal year 2007 restructuring plan.

Share-based compensation expense has been included in the Company’s unaudited condensed consolidated statement of earnings as follows:


					Fiscal Quarter Ended				Six Months Ended
	Fiscal Quarter Ended				April 2, 2010		April 3, 2009		April 2, 2010		April 3, 2009
	January 1, 2010		January 2, 2009		April 2, 2010				April 2, 2010		April 3, 2009
(in thousands)							April 3, 2009
Cost of sales	$	63	$	133	$	47	$	87	$	110	$	220
Selling, general and administrative		1,108		2,119		746		1,834		1,854		3,953
Research and development		61		114		48		24		109		138

Total	$	1,232	$	2,366	$	841	$	1,945	$	2,073	$	4,311

Stock Options.Under the Omnibus Stock Plan (“OSP”), the Company periodically grants stock options to officers, directors and employees. The exercise price for stock options granted under the OSP may not be less than 100% of the fair market value at the date of the grant. Options granted are exercisable at the times and on the terms established by the Compensation Committee, but not later than ten years after the date of grant (except in the event of death, after which an option is exercisable for three years). Options granted generally become exercisable in cumulative installments of one-third each year commencing one year following the date of grant. In accordance with covenants of the Merger Agreement, the Company did not grant any stock options under the OSP during the first ~~quarter~~six months of fiscal year 2010.

The following table summarizes stock option activity under the OSP for the ~~fiscal quarter~~six months ended ~~January 1,~~April 2, 2010:


					Shares		Weighted Average Exercise Price


	Shares		Weighted Average Exercise Price
	(in thousands)				(in thousands)
Outstanding at October 2, 2009	1,786		$	43.80	1,786		$	43.80
Exercised	(38	)	$	36.85	(103	)	$	37.40
Cancelled or expired	(4	)	$	46.30	(6	)	$	46.89

Outstanding at January 1, 2010	1,744		$	43.94
Outstanding at April 2, 2010					1,677		$	44.18

As of ~~January 1,~~April 2, 2010, the unrecognized share-based compensation balance related to stock options was ~~$2.4~~$2.0 million. This amount will be recognized as expense using the straight-line attribution method over a weighted-average amortization period of ~~1.2~~1.0 years.

Restricted (Nonvested) Stock.Under the OSP, the Company also periodically grants restricted (nonvested) common stock to employees. Such grants are valued as of the grant date. These amounts are recognized by the Company as share-based compensation expense ratably over their respective vesting periods, which range from one to three years. In accordance with covenants of the Merger Agreement, the Company did not grant any restricted (nonvested) common stock under the OSP during the first ~~quarter~~six months of fiscal year 2010.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes restricted (nonvested) common stock activity under the OSP for the ~~fiscal quarter~~six months ended ~~January 1,~~April 2, 2010:


	Shares		Weighted Average Grant Date Fair Value		Shares		Weighted Average Grant Date Fair Value
	(in thousands)				(in thousands)
Outstanding and unvested at October 2, 2009	156		$	32.51	156		$	32.51
Vested⁽¹⁾	(24	)	$	55.91	(60	)	$	35.47
Forfeited	—		$	—	—			—

Outstanding and unvested at January 1, 2010	132		$	28.34
Outstanding and unvested at April 2, 2010					96		$	30.66

As of ~~January 1,~~April 2, 2010, there was a total of ~~$2.4~~$2.0 million in unrecognized share-based compensation expense related to restricted stock granted under the OSP. This expense will be recognized over a weighted-average amortization period of ~~1.9~~1.7 years.

Non-Employee Director Stock Units. Under the terms of the OSP, on the first business day following each annual meeting of the Company’s stockholders, each person then serving as a non-employee director is automatically granted stock units having an initial value of $45,000. The stock units will vest upon termination of the director’s service on the Board of Directors and will then be satisfied by issuance of shares of the Company’s common stock. Each non-employee director who holds stock units will not have rights as a stockholder with respect to the shares issuable thereunder until such shares are paid out. The stock units are not transferable, except to the non-employee director’s designated beneficiary or estate in the event of his or her death. During the fiscal quarter ended April 3, 2009, the Company granted stock units with an aggregate value of $225,000 to non-employee members of its Board of Directors (of which there were five) and recognized the total value as share-based compensation expense at the time of grant. In accordance with covenants of the Merger Agreement, the Company did not grant any stock units under the OSP during the first six months of fiscal year 2010.

Employee Stock Purchase Plan.During the fiscal quarter ended January 1, 2010, employees purchased approximately 21,100 shares for $0.7 million under the Company’s Employee Stock Purchase Plan (“ESPP”). During the fiscal quarter and six months ended ~~January 2,~~April 3, 2009, employees purchased approximately ~~27,100~~42,000 shares for ~~$0.9~~$1.2 million and 69,000 shares for $2.1 million, respectively, under the ESPP. On the first day of fiscal year 2010, the Company suspended employee contributions for future purchases under the ESPP in accordance with covenants of the Merger Agreement.

Stock Repurchase Programs. In February 2008, the Company’s Board of Directors approved a stock repurchase program under which the Company iswas authorized to utilize up to $100 million to repurchase shares of its common stock. During the first six months of fiscal ~~quarter ended January 1,~~year 2010, the Company did not repurchase any shares of its common stock under this authorization. This repurchase program expired on December 31, 2009.

Other Stock Repurchases.During the fiscal quarter and six months ended ~~January 1,~~April 2, 2010, the Company repurchased and retired ~~4,000~~13,000 and 17,000 shares, respectively, tendered to it by employees in settlement of employee tax withholding obligations due from those employees upon the vesting of restricted stock.

The Company’s U.S. federal, state and local and foreign income tax returns are subject to audit by relevant tax authorities. Although the timing and outcome of income tax audits is highly uncertain, the Company has recorded liabilities for associated unrecognized tax benefits. It is possible that certain unrecognized tax benefits could decrease by $0.8 million in the next twelve months due to the lapse of certain statutes of limitation and result in a reduction in income tax expense. Any such reduction could be impacted by other changes in unrecognized tax benefits.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Basic earnings per share are calculated based on net earnings and the weighted-average number of shares of common stock outstanding during the reported period. Diluted earnings per share are calculated similarly, except that the weighted-average number of common shares outstanding during the period is increased by the number of

~~NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)~~

additional shares of common stock that would have been outstanding if the dilutive potential shares of common stock had been issued. The dilutive effect of potential common stock (including outstanding stock options, nonvested restricted stock and non-employee director stock units) is reflected in diluted earnings per share by application of the treasury stock method, which includes consideration of share-based compensation and the tax benefit thereon.

For both the fiscal ~~quarters~~quarter and six months ended ~~January 1,~~April 2, 2010, options to purchase 292,000 shares were excluded from the calculation of diluted earnings per share as their effect was anti-dilutive. For the fiscal quarter and ~~January 2,~~six months ended April 3, 2009, options to purchase ~~293,000~~1,875,000 and ~~1,790,000~~1,828,000 shares, respectively, were excluded from the calculation of diluted earnings per share as their effect was anti-dilutive.

A reconciliation of weighted-average basic shares outstanding to weighted-average diluted shares outstanding follows:


	Fiscal Quarter Ended		Fiscal Quarter Ended		Six Months Ended
	January 1, 2010	January 2, 2009	April 2, 2010	April 3, 2009	April 2, 2010	April 3, 2009
(in thousands)
Weighted-average basic shares outstanding	28,863	28,854	28,940	28,853	28,902	28,853
Net effect of dilutive potential common stock	383	96	363	99	361	110

Weighted-average diluted shares outstanding	29,246	28,950	29,303	28,952	29,263	28,963

During the first quarter of fiscal year 2010, the Company adopted ASC 260-10-45 to 65,Earnings per Share, which addresses whether nonvested instruments granted in share-based payment transactions that contain non-forfeitable rights to dividends or dividend equivalents are participating securities subject to the two-class method of computing earnings per share. Although our nonvested restricted stock awards are considered participating securities, they are not material as compared with total weighted average diluted shares outstanding and are therefore not presented using the two-class method.

For financial reporting purposes, the Company’s operations are grouped into two business segments: Scientific Instruments and Vacuum Technologies. The Scientific Instruments segment designs, develops, manufactures, markets, sells and services equipment and related software, consumable products, accessories and services for a broad range of life science, environmental, energy, and applied research and other applications requiring identification, quantification and analysis of the composition or structure of liquids, solids or gases. The Vacuum Technologies segment designs, develops, manufactures, markets, sells and services vacuum products and related accessories and services used to create, contain, control, measure and test vacuum environments in a broad range of life science, industrial and other applications requiring ultra-clean or high-vacuum environments. These segments were determined in accordance with ASC 280,Segment Reporting.

General corporate costs include shared costs of legal, tax, accounting, treasury, insurance and certain other management costs. A portion of the indirect and common costs has been allocated to the segments through the use of estimates. Also, transactions between segments are accounted for at cost and are not included in sales. Accordingly, the following information is provided for purposes of achieving an understanding of operations, but might not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies might not be meaningful.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)


											Sales						Sales
											Fiscal Quarter Ended						Six Months Ended
											April 2, 2010			April 3, 2009			April 2, 2010			April 3, 2009
(in millions)
Scientific Instruments											$	171.1		$	170.9		$	337.7		$	342.7
Vacuum Technologies												40.8			34.5			75.3			71.0

Total industry segments											$	211.9		$	205.4		$	413.0		$	413.7


	Sales				Pretax Earnings						Pretax Earnings						Pretax Earnings
	Fiscal Quarter Ended				Fiscal Quarter Ended						Fiscal Quarter Ended						Six Months Ended
	January 1, 2010		January 2, 2009		January 1, 2010			January 2, 2009			April 2, 2010			April 3, 2009			April 2, 2010			April 3, 2009
(in millions)
Scientific Instruments	$	166.6	$	171.8	$	9.4		$	16.4		$	9.6		$	12.4		$	19.1		$	28.8
Vacuum Technologies		34.6		36.4		7.1			7.1			9.3			6.7			16.5			13.7

Total industry segments		201.2		208.2		16.5			23.5			18.9			19.1			35.6			42.5
General corporate		—		—		(4.0	)		(3.6	)		(4.3	)		(3.6	)		(8.5	)		(7.1	)
Interest income		—		—		0.5			0.6			0.9			0.3			1.4			0.9
Interest expense		—		—		(0.3	)		(0.3	)		(0.3	)		(0.3	)		(0.7	)		(0.7	)

Total	$	201.2	$	208.2	$	12.7		$	20.2		$	15.2		$	15.5		$	27.8		$	35.6

In December 2008, the FASB issued additional disclosure requirements for plan assets of a defined benefit pension or other postretirement plan. The required disclosures include a description of the Company’s investment policies and strategies, the fair value of each major category of plan assets, the inputs and valuation techniques used to measure the fair value of plan assets, the effect of fair value measurements using significant unobservable inputs on changes in plan assets and the significant concentrations of risk within plan assets. These additional disclosures are effective for annual disclosure for fiscal years ending after December 15, 2009. The Company does not expect the adoption of the new disclosure requirements to have a material impact on its financial condition or results of operations.

In October 2009, the FASB issued two new accounting standards that provide guidance for revenue recognition. The first standard revises guidance for arrangements with multiple deliverables. This accounting standard replaces the term fair value in the revenue recognition allocation guidance with selling price and establishes a hierarchy for determining the selling price of a deliverable. The selling price of each deliverable will first be based on vendor specific objective evidence (“VSOE”) if available, second on third-party evidence (“~~TPE’~~TPE”) if VSOE is not available and third on estimated selling price if neither VSOE nor TPE is available. In addition, the residual method is no longer permitted as vendors are now required to allocate arrangement consideration using the relative selling price method. The second new accounting standard excludes from the scope of software revenue recognition software components contained in, and essential to the functionality of, tangible products. These two new accounting standards require expanded qualitative and quantitative disclosures and are effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption is permitted. The Company does not expect the adoption of these accounting standards in the first quarter of fiscal year 2011 to have a material impact on its financial condition or results of operations.

In January 2010, the FASB issued an accounting standard update that clarifies and provides additional disclosure requirements related to recurring and non-recurring fair value measurements and employers’ disclosures about postretirement benefit plan assets. These additional disclosures are effective for interim and annual reporting periods beginning after December 15, 2009. The Company does not expect the adoption of this accounting standard update in the second quarter of fiscal year 2010 to have a material impact on its financial condition or results of operations.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Throughout this Report, and particularly in thisItem 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations, there are forward-looking statements that are based upon our current expectations, estimates and projections and that reflect our beliefs and assumptions based upon information available to us at the date of this Report. In some cases, you can identify these statements by words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” and other similar terms. These forward-looking statements include (but are not limited to) those relating to the timing and amount of anticipated restructuring and other related costs and related cost savings as well as anticipated capital expenditures in fiscal year 2010.

We caution investors that forward-looking statements are only our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements. Some of the important factors that could cause our results to differ are discussed inItem 1A—Risk Factors in our Annual Report on Form 10-K for the fiscal year ended October 2, 2009. We encourage you to read that section carefully.

Other risks and uncertainties that could cause actual results to differ materially from those in our forward-looking statements include, but are not limited to, the following: the pace and extent of improvements in global economic conditions; whether we will succeed in new product development, release, commercialization, performance and acceptance; whether we can achieve growth in sales for life science, environmental, energy or applied research and other applications; whether we can achieve sales growth in Europe, North America, Asia Pacific or Latin America; risks arising from the timing of shipments, installations and the recognition of revenues on certain research products, including nuclear magnetic resonance (“NMR”) spectroscopy systems, magnetic resonance (“MR”) imaging systems and fourier transform mass spectrometry (“FTMS”) systems and superconducting magnets; the impact of shifting product mix on profit margins; competitive products and pricing; economic conditions in our various product and geographic markets; whether we will see continued and timely delivery of key raw materials and components by suppliers; foreign currency fluctuations that could adversely impact revenue growth or earnings; whether we will see continued investment in capital equipment, in particular given the global liquidity and credit conditions; demand from customers that operate in cyclical industries; the extent to which global liquidity and credit conditions impact the collectability of accounts receivable from our customers; the extent and timing of government funding for research; the actual costs, timing and benefits of restructuring activities (such as our previously announced employee reductions, our Northern California operations consolidation and other actions) and other efficiency improvement activities (such as our global procurement, lower-cost manufacturing and outsourcing initiatives); the timing and amount of share-based compensation; the ability of our company and Agilent Technologies, Inc. (“Agilent”) to complete the announced acquisition of our company by Agilent (the “Merger”); the affect on our business operations and financial results of the announcement, the pendency, and activities relating to the completion of the Merger, including the ~~recently announced~~ undertaking to divest certain of the Company’s product lines in order to secure regulatory approval to complete the Merger; the affect of certain restrictions on our ability to conduct our business under the Merger agreement with Agilent; and other risks detailed from time to time in our filings with the U.S. Securities and Exchange Commission (the “SEC”). We undertake no special obligation to update any forward-looking statements, whether in response to new information, future events or otherwise.

~~First~~Second Quarter of Fiscal Year 2010 Compared to ~~First~~Second Quarter of Fiscal Year 2009

For financial reporting purposes, our operations are grouped into two reportable business segments: Scientific Instruments and Vacuum Technologies. The following table presents comparisons of our sales and operating earnings for each of those segments and in total for the ~~first quarter~~second quarters of fiscal years 2010 and 2009:


	Fiscal Quarter Ended										Increase (Decrease)					Fiscal Quarter Ended										Increase (Decrease)
	January 1, 2010					January 2, 2009					Increase (Decrease)					April 2, 2010					April 3, 2009					Increase (Decrease)
	$			% of Sales		$			% of Sales		$			%		$			% of Sales		$			% of Sales		$			%
(dollars in millions)
Sales by Segment:
Scientific Instruments	$	166.6		82.8	%	$	171.8		82.5	%	$	(5.2	)	(3.0	)%	$	171.1		80.8	%	$	170.9		83.2	%	$	0.2		0.1	%
Vacuum Technologies		34.6		17.2			36.4		17.5			(1.8	)	(5.0	)		40.8		19.2			34.5		16.8			6.3		18.1

Total company	$	201.2		100.0	%	$	208.2		100.0	%	$	(7.0	)	(3.4	)%	$	211.9		100.0	%	$	205.4		100.0	%	$	6.5		3.1	%


Operating Earnings by Segment:
Scientific Instruments	$	9.4		5.7	%	$	16.4		9.6	%	$	(7.0	)	(42.6	)%	$	9.6		5.6	%	$	12.4		9.6	%	$	(2.8	)	(22.5	)%
Vacuum Technologies		7.1		20.6			7.1		19.3			—		—			9.3		22.9			6.7		19.3			2.6		40.6

Total segments		16.5		8.2			23.5		11.3			(7.0	)	(29.5	)		18.9		9.0			19.1		11.3			(0.2	)	(0.5	)
General corporate		(4.0	)	(2.0	)		(3.6	)	(1.7	)		(0.4	)	(14.5	)		(4.3	)	(2.1	)		(3.6	)	(1.7	)		(0.7	)	(22.1	)

Total company	$	12.5		6.2	%	$	19.9		9.6	%	$	(7.4	)	(37.4	)%	$	14.6		6.9	%	$	15.5		9.6	%	$	(0.9	)	(5.7	)%

Scientific Instruments. ~~The decrease in~~ Scientific Instruments sales ~~was primarily attributable~~were nearly flat in the second quarter of fiscal year 2010 compared to the prior-year quarter. Higher sales of our low-volume, high selling price research products (the timing of which is often impacted by factors such as laboratory readiness and access to customer sites, duration of installations and availability of key components and installation personnel) and, to a lesser extent, consumable products were offset by lower sales ~~volume and lower average selling prices~~ of ~~certain~~ analytical ~~instruments products partly offset by increased sales volume of our research products and consumables~~instrument products. The weaker U.S. dollar also had a positive impact on reported revenues. ~~Revenue in the first quarter~~The lower sales of ~~fiscal year 2010~~analytical instrument products was ~~affected by~~primarily attributable to the negative impact of customers’ uncertainty and employee and other disruptions related to the announcement and pendency of the acquisition by Agilent, ~~(particularly for~~which adversely impacted sales volume and average selling prices of certain analytical instruments products) and by the impact of continued global economic weakness on capital equipment spending. The increase in research products revenue was primarily due to unusually low sales of these products in the prior year quarter caused primarily by delays related to laboratory readiness and access to customer sites, duration of installations and availability of key components or installation personnel.instrument products.

Scientific Instruments operating earnings for the ~~first~~second quarter of fiscal year 2010 included ~~$1.8~~$3.2 million of costs resulting from the pending acquisition by Agilent and acquisition-related intangible amortization of $1.8 ~~million and restructuring and other related costs of $0.7~~ million. In comparison, Scientific Instruments operating earnings for the ~~first~~second quarter of fiscal year 2009 included acquisition-related intangible amortization of ~~$2.1~~$1.7 million and restructuring and other related costs of ~~$1.6~~$6.2 million. Excluding the impact of these items, operating earnings decreased as a percentage of sales primarily due to ~~the negative impact of product mix and~~ lower average selling prices for certain analytical ~~instruments~~instrument products and the impact of the weaker U.S. dollar (which was ~~favorable to reported sales but~~ unfavorable to reported operating ~~margins)~~margins, but favorable to reported sales), partially offset by ~~cost reduction activities implemented~~$1.5 million received from a customer in ~~the second quarter~~settlement of ~~fiscal year 2009.~~an unfulfilled volume purchase arrangement.

Vacuum Technologies. The ~~decrease~~increase in Vacuum Technologies sales was driven mainly by ~~lower~~higher sales volume of products for both industrial and life science applications, primarily due to the impact of ~~continued~~improved global economic ~~weakness~~conditions on capital equipment spending ~~partly offset by~~as well as the positive impact of the weaker U.S. dollar on reported ~~revenues.~~sales.

~~The~~Vacuum Technologies operating earnings for the second quarter of fiscal year 2009 included the impact of restructuring and other related costs of $0.8 million. Excluding the impact of these costs, the increase in Vacuum Technologies operating earnings as a percentage of sales was primarily due to the positive impact of higher sales volumes and cost reduction activities implemented in the second quarter of fiscal year 2009, partially offset by the ~~negative impact of lower sales volume and the~~ weaker U.S. dollar (which was ~~favorable to reported sales but~~ unfavorable to reported operating ~~margins)~~margins, but favorable to reported sales).

The following table presents comparisons of our sales and other selected consolidated financial results for the ~~first quarter~~second quarters of fiscal years 2010 and 2009:


	Fiscal Quarter Ended															Fiscal Quarter Ended
	January 1, 2010					January 2, 2009					Increase (Decrease)					April 2, 2010					April 3, 2009					Increase (Decrease)
				% of					% of										% of					% of
	$			Sales		$			Sales		$			%		$			Sales		$			Sales		$			%
(dollars in millions, except per share data)
Sales:	$	201.2		100.0	%	$	208.2		100.0	%	$	(7.0	)	(3.4	)%
Sales																$	211.9		100.0	%	$	205.4		100.0	%	$	6.5		3.1	%

Gross profit		86.9		43.2			95.3		45.8			(8.4	)	(8.9	)		89.4		42.2			89.5		43.6			(0.1	)	(0.2	)

Operating expenses:
Selling, general and administrative		59.9		29.8			60.9		29.2	%		(1.0	)	(1.7	)		59.8		28.2			59.3		28.9			0.5		0.8
Research and development		14.5		7.2			14.5		7.0			—		—			15.0		7.1			14.7		7.2			0.3		1.7

Total operating expenses		74.4		37.0			75.4		36.2			(1.0	)	(1.3	)		74.8		35.3			74.0		36.1			0.8		1.0


Operating earnings		12.5		6.2			19.9		9.6			(7.4	)	(37.4	)		14.6		6.9			15.5		7.5			(0.9	)	(5.7	)
Interest income		0.5		0.3			0.5		0.3			—		—			0.9		0.4			0.3		0.2			0.6		172
Interest expense		(0.3	)	(0.2	)		(0.3	)	(0.2	)		—		—			(0.3	)	(0.1	)		(0.3	)	(0.2	)		—		—
Income tax expense		(4.6	)	(2.3	)		(7.1	)	(3.4	)		2.5		35.6			(5.5	)	(2.6	)		(5.3	)	(2.5	)		(0.2	)	(4.1	)

Net earnings	$	8.1		4.0	%	$	13.0		6.3	%	$	(4.9	)	(38.1	)%	$	9.7		4.6	%	$	10.2		5.0	%	$	(0.5	)	(5.0	)%

Net earnings per diluted share	$	0.28				$	0.45				$	(0.17	)			$	0.33				$	0.35				$	(0.02	)

Sales. As discussed under the headingSegment Results above, sales by our Scientific Instruments and Vacuum Technologies segments in the ~~first~~second quarter of fiscal year 2010 ~~decreased~~increased by ~~3.0%~~0.1% and ~~5.0%~~18.1%, respectively, compared to the prior-year quarter. On a consolidated basis, sales ~~declined 3.4%~~increased by 3.1% in the ~~first~~second quarter of fiscal year 2010. This ~~decrease~~increase was primarily due to increased sales volumes of Vacuum Technologies products and the positive impact of continued global economic weakness on capital equipment spending and by customers’ uncertainty and employee and other disruptions related to the announcement and pendency of the acquisition by Agilent. Reported sales were positively impacted by the weaker U.S. dollar, which weakened approximately 5%4% on a weighted-average basis compared to most major currencies in which we sell products and services.

For geographic reporting purposes, we refer to four regions – North America (excluding Mexico), Europe (including the Middle East and Africa), Asia Pacific (including India) and Latin America (including Mexico). Sales by geographic region in the ~~first~~second quarters of fiscal years 2010 and 2009 were as follows:


	Fiscal Quarter Ended													Fiscal Quarter Ended
	January 1, 2010				January 2, 2009				Increase (Decrease)					April 2, 2010				April 3, 2009				Increase (Decrease)
	$		% of Sales		$		% of Sales		$			%		$		% of Sales		$		% of Sales		$			%
(dollars in millions)
Geographic Region
North America	$	62.4	31.0	%	$	65.2	31.3	%	$	(2.8	)	(4.3	)%	$	69.3	32.7	%	$	66.4	32.4	%	$	2.9		4.2	%
Europe		80.1	39.8			83.9	40.3			(3.8	)	(4.5	)		70.7	33.4			77.9	37.9			(7.2	)	(9.2	)
Asia Pacific		46.9	23.3			47.1	22.6			(0.2	)	(0.5	)		59.3	28.0			48.4	23.5			10.9		22.5
Latin America		11.8	5.9			12.0	5.8			(0.2	)	(2.4	)		12.6	5.9			12.7	6.2			(0.1	)	(0.7	)

Total company	$	201.2	100.0	%	$	208.2	100.0	%	$	(7.0	)	(3.4	)%	$	211.9	100.0	%	$	205.4	100.0	%	$	6.5		3.1	%

Sales in North America increased in the second quarter of fiscal year 2010 compared to the prior year quarter primarily due to higher sales of low-volume, high-selling price research products partly offset by decreased sales of analytical instrument products. The decrease in sales in ~~all regions~~Europe was primarily due to lower sales of analytical instrument products and research products, partly offset by increased sales of vacuum products. The increase in sales in Asia Pacific was primarily attributable to ~~the negative impact~~higher sales of ~~continued global economic weakness on capital equipment spending~~research products and ~~the negative impact~~vacuum products, partly offset by decreased sales of analytical instruments. Sales of analytical instrument products were negatively impacted in all four regions by customers’ uncertainty and employee and other disruptions related to the announcement and pendency of the acquisition by Agilent. ~~Reported~~

As described above, the sales ~~outside~~increase in North America ~~were favorably impacted by~~was more pronounced due to the ~~weakening~~timing of sales of certain low-volume, high-selling price research products. We do not consider this geographic shift to be indicative of any particular trend for research products as a whole, but rather to be reflective of the ~~U.S. dollar compared to the prior year quarter.~~variability in results that these low-volume, high-selling price research products can create.

Gross Profit. Gross profit for the ~~first~~second quarter of fiscal year 2010 reflects the impact of $1.6 million in amortization expense relating to acquisition-related intangible ~~assets and $0.2 million in restructuring and other related costs.~~assets. In comparison, gross profit for the ~~first~~second quarter of fiscal year 2009 reflects the impact of ~~$1.6~~$1.5 million in amortization expense relating to acquisition-related intangible assets and ~~$0.9~~$2.3 million in restructuring and other related costs. Excluding the impact of these items, gross profit as a percentage of sales decreased primarily due to ~~product mix,~~ lower average selling prices of certain analytical ~~instruments~~instrument products and the impact of the weaker U.S. dollar (which was unfavorable to reported gross profit margins, but favorable to reported sales) partially offset by cost reduction activities implemented in the second quarter of fiscal year ~~2009.~~2009 and the positive impact of higher sales volume for the Vacuum Technologies segment.

Selling, General and Administrative. Selling, general and administrative expenses for the ~~first~~second quarter of fiscal year 2010 included ~~$3.2~~$4.3 million of costs resulting from the pending acquisition by Agilent and $0.2 million in amortization expense relating to acquisition-related intangible assets. In comparison, selling, general and administrative expenses for the second quarter of fiscal year 2009 included $0.2 million in amortization expense relating to acquisition-related intangible assets and $0.1 million in restructuring and other related costs. In comparison, selling, general and administrative expenses for the first quarter of fiscal year 2009 included $0.5 million in amortization expense relating to acquisition-related intangible assets and $0.6$3.8 million in restructuring and other related costs. Excluding the impact of these items, ~~the~~ selling, general and administrative expenses as a percentage of sales ~~declined~~decreased primarily due to ~~cost reduction activities implemented~~$1.5 million received from a customer in ~~the second quarter~~settlement of ~~fiscal year 2009, partly offset by the unfavorable impact of the weaker U.S. dollar.~~an unfulfilled volume purchase agreement.

Research and Development. Research and development expenses for the ~~first quarter of fiscal year 2010 reflect the impact of restructuring and other related costs of $0.4 million. In comparison, research and development expenses for the first~~second quarter of fiscal year 2009 reflect the impact of restructuring and other related costs of ~~$0.2~~$0.9 million. Excluding the impact of ~~these items,~~this item, research and development expenses as a percentage of sales ~~were essentially flat compared~~increased slightly due to ~~the first quarter of fiscal 2009.~~higher costs associated with new product introductions.

retention and relocation costs and accelerated depreciation of assets disposed upon the closure of facilities). Of the $10.6 million in other restructuring-related costs, $0.7 million was recorded in the first quarter of fiscal year 2010 which was primarily related to the fiscal year 2007 restructuring plan.

The following table sets forth changes in the Company’s aggregate liability relating to all ongoing restructuring plans during the ~~first~~second quarter of fiscal year 2010:


	Employee- Related			Facilities- Related			Total			Employee- Related			Facilities- Related			Total
(in thousands)
Balance at October 2, 2009	$	579		$	398		$	977
Charges to expense, net		34			—			34
Balance at January 1, 2010										$	363		$	386		$	749
Cash payments		(248	)		(10	)		(258	)		(158	)		—			(158	)
Foreign currency impacts and other adjustments		(2	)		(2	)		(4	)		(7	)		(17	)		(24	)

Balance at January 1, 2010	$	363		$	386		$	749
Balance at April 2, 2010										$	198		$	369		$	567

Restructuring Cost Savings. The following table sets forth the estimated annual cost savings for each plan, when they were initiated, as well as where those cost savings were expected to be realized:

These estimated cost savings ~~are expected to~~ impact cost of sales, selling, general and administrative expenses and research and development expenses. Some of these cost savings have been and will continue to be reinvested in other parts of our business, for example, as part of our continued emphasis on IRD and consumable products. In addition, unrelated cost increases in other areas of our operations have and could in the future offset some or all of these cost savings. Although it is difficult to quantify with any precision our actual cost savings to date from these activities, some of which are still ongoing, we currently believe that the ultimate savings realized will not differ materially from these estimates.

Interest Income.The increase in interest income was primarily due to higher interest rates on certain invested cash balances during the second quarter of fiscal 2010 compared to the second quarter of fiscal year 2009.

Income Tax Expense. The effective income tax rate was ~~36.2%~~36.4% for the ~~first~~second quarter of fiscal year 2010, compared to ~~35.3%~~34.3% for the ~~first~~second quarter of fiscal year 2009. The higher effective tax rate in the ~~first~~second quarter of fiscal year 2010 was primarily due to certain non-deductible costs associated with the pending acquisition by Agilent and the expiration of the U.S. federal research and development tax credit.

Net Earnings. Net earnings for the second quarter of fiscal year 2010 reflect the after-tax impacts of $4.3 million of pre-tax costs resulting from the pending acquisition by Agilent and $1.8 million in pre-tax acquisition-related intangible amortization. Net earnings for the second quarter of fiscal year 2009 reflect the after-tax impacts of $1.7 million in pre-tax acquisition-related intangible amortization and $7.0 million in pre-tax restructuring and other related costs. Excluding the after-tax impact of these items, the decrease in net earnings in the second quarter of fiscal year 2010 was primarily attributable to lower gross profits as a percentage of sales.

First Six Months of Fiscal Year 2010 Compared to First Six Months of Fiscal Year 2009

The following table presents comparisons of our sales and operating earnings for each of those segments and in total for the first six months of fiscal years 2010 and 2009:

Scientific Instruments. The decrease in Scientific Instruments sales in the first six months of fiscal year 2010 was due to lower sales of analytical instrument products. These lower sales were primarily attributable to the negative impact of customers’ uncertainty and employee and other disruptions related to the announcement and pendency of the acquisition by Agilent, which adversely impacted sales volumes and average selling prices of certain analytical instrument products. The decrease in sales of analytical instrument products was partly offset by increased sales of low-volume, high-selling price research products (the timing of which is often impacted by factors such as laboratory readiness and access to customer sites, duration of installations and availability of key components and installation personnel) and to a lesser extent, higher sales of consumables products. The weaker U.S. dollar also had a positive impact on reported revenues.

Scientific Instruments operating earnings for the first six months of fiscal year 2010 included $5.0 million of costs resulting from the pending acquisition by Agilent, acquisition-related intangible amortization of $3.6 million and restructuring and other related costs of $0.7 million. In comparison, Scientific Instruments operating earnings for the first six months of fiscal year 2009 included acquisition-related intangible amortization of $3.8 million and restructuring and other related costs of $7.8 million. Excluding the impact of these items, operating earnings decreased as a percentage of sales primarily due to the negative impact of product mix and lower average selling prices for analytical instrument products and the weaker U.S. dollar (which was favorable to reported sales but unfavorable to reported operating margins), partially offset by cost reduction activities implemented in the second quarter of fiscal year 2009.

Vacuum Technologies. The increase in Vacuum Technologies sales was driven mainly by higher sales volume of products for both industrial and life science applications, primarily due to the impact of improved global economic conditions on capital equipment spending and the positive impact of the weaker U.S. dollar on reported revenues.

The increase in Vacuum Technologies operating earnings as a percentage of sales was primarily due to the impact of higher sales volumes and the positive impact of cost reduction activities implemented in the second quarter of fiscal year 2009.

The following table presents comparisons of our sales and other selected consolidated financial results for the first six months of fiscal years 2010 and 2009:

Sales. As discussed under the headingSegment Results above, sales by our Scientific Instruments and Vacuum Technologies segments in the first six months of fiscal year 2010 decreased by 1.5% and increased by 6.2%, respectively, compared to the first six months of the prior-year. On a consolidated basis, sales were essentially flat compared to the prior year. Reported sales were positively impacted by the weaker U.S. dollar, which weakened approximately 4% on a weighted-average basis compared to most major currencies in which we sell products and services.

Sales by geographic region in the first six months of fiscal years 2010 and 2009 were as follows:

Sales in North America were flat in the first six months of fiscal year 2010 compared to the prior year period primarily attributable to higher sales of low-volume, high-selling price research products offset by lower sales of analytical instrument products and vacuum products. The decrease in sales in Europe was primarily due to decreased sales of analytical instrument products. The increase in sales in Asia Pacific was primarily attributable to increased sales of research products and vacuum products, partly offset by decreased sales of analytical instrument products. Sales of analytical instrument products were negatively impacted in all four regions by customers’ uncertainty and employee and other disruptions related to the announcement and pendency of the acquisition by Agilent.

As described above, the higher sales of research products in North America was more pronounced due to the timing of sales of certain low-volume, high-selling price products. We do not consider this geographic shift to be indicative of any particular trend for research products as a whole, but rather to be reflective of the variability in results that these low-volume, high-selling price research products can create.

Gross Profit. Gross profit for the first six months of fiscal year 2010 reflects the impact of $3.2 million in amortization expense relating to acquisition-related intangible assets and $0.2 million in restructuring and other related costs. In comparison, gross profit for the first six months of fiscal year 2009 reflects the impact of $3.1 million in amortization expense relating to acquisition-related intangible assets and $3.2 million in restructuring and other related costs. Excluding the impact of these items, gross profit as a percentage of sales decreased primarily due to product mix, lower average selling prices of certain analytical instrument products and the weaker U.S. dollar (which was unfavorable to reported gross profit, but favorable to reported sales) partially offset by cost reduction activities implemented in the second quarter of fiscal year 2009.

Selling, General and Administrative. Selling, general and administrative expenses for the first six months of fiscal year 2010 included $7.5 million of costs resulting from the pending acquisition by Agilent and $0.4 million in amortization expense relating to acquisition-related intangible assets and $0.1 million in restructuring and other related costs. In comparison, selling, general and administrative expenses for the first six months of fiscal year 2009 included $0.7 million in amortization expense relating to acquisition-related intangible assets and $4.4 million in restructuring and other related costs. Excluding the impact of these items, selling, general and administrative expenses as a percentage of sales declined due to cost reduction activities implemented in the second quarter of fiscal year 2009 and $1.5 million received from a customer in settlement of an unfulfilled volume purchase agreement.

Research and Development. Research and development expenses for the first six months of fiscal year 2010 reflect the impact of restructuring and other related costs of $0.4 million. In comparison, research and development expenses for the first six months of fiscal year 2009 reflect the impact of restructuring and other related costs of $1.1 million. Excluding the impact of these items, research and development expenses as a percentage of sales increased slightly due to higher costs associated with new product introductions.

Restructuring Activities. We have committed to several restructuring plans in order to improve operational efficiencies, centralize functions, reallocate resources and reduce operating costs.From the respective inception dates of these plans through April 2, 2010, we have incurred a total of $12.2 million in restructuring expense and a total of $10.6 million in other costs related directly to those plans (comprised primarily of employee retention and relocation costs and accelerated depreciation of assets disposed upon the closure of facilities). Of the $10.6 million in other restructuring-related costs, $0.7 million was recorded in the first six months of fiscal year 2010 which was primarily related to the fiscal year 2007 restructuring plan.

The following table sets forth changes in the Company’s aggregate liability relating to all ongoing restructuring plans during the first six months of fiscal year 2010:

Income Tax Expense. The effective income tax rate was 36.3% for the first six months of fiscal year 2010, compared to 34.9% for the first six months of fiscal year 2009. The higher effective tax rate in the first six months of fiscal year 2010 was primarily due to certain non-deductible costs associated with the pending acquisition with Agilent and the expiration of the U.S. federal research and development tax credit.

Net Earnings. Net earnings for the first ~~quarter~~six months of fiscal year 2010 reflect the after-tax impacts of ~~$3.2~~$7.5 million of pre-tax costs resulting from the pending acquisition by Agilent, ~~$1.8~~$3.6 million in pre-tax acquisition-related intangible amortization and $0.7 million in pre-tax restructuring and other related costs. Net earnings for the first ~~quarter~~six months of fiscal year 2009 reflect the after-tax impacts of ~~$2.1~~$3.8 million in pre-tax acquisition-related intangible amortization and ~~$1.7~~$8.7 million in pre-tax restructuring and other related costs. Excluding the after-tax impact of these items, the decrease in net earnings in the first ~~quarter~~six months of fiscal year 2010 was primarily attributable to lower gross profits as a percentage of sales.

The diversity of our products, the applications we serve and our worldwide distribution position us well. ~~However,~~While the global economic environment has recently shown some moderate improvement, we continue to operate in ~~difficult~~uncertain global economic conditions. The uncertainty of these conditions, as well as customers’ uncertainty and employee and other disruptions related to the announcement and pendency of our acquisition by Agilent and related divestitures being undertaken in order to obtain regulatory approval of that acquisition, make it difficult for us to project our near-term results of operations. These conditions could further impact our business and have an adverse effect on our financial position, results of operations or cash flows.In addition, we have incurred and will continue to incur legal and other expenses in connection with the pending acquisition by Agilent, which could have an adverse effect on our financial position, results of operations or cash flows.

We generated ~~$22.7~~$26.5 million of cash from operating activities in the first ~~quarter~~six months of fiscal year 2010, compared to ~~$16.9~~$50.5 million generated in the first ~~quarter~~six months of fiscal year 2009. The ~~increase~~decrease in operating cash flows was primarily due to ~~increased advance payments~~higher collections of accounts receivable in the first six months of fiscal 2009, which resulted from ~~customers, reduced inventory purchases, and increased net earnings after adjustments for noncash income and expenses partly offset by decreased cash collections (due to lower prior-quarter revenues).~~record sales levels in the fourth quarter of fiscal year 2008.

We used ~~$3.4~~$4.2 million of cash for investing activities in the first ~~quarter~~six months of fiscal year 2010, which compares to ~~$2.5~~$12.1 million used for investing activities in the first ~~quarter~~six months of fiscal year 2009. In the first quarter of fiscal year 2009, we received a $5.0 million non-refundable first surrender payment under an agreement with VMS in which we agreed to surrender to them the sublease for our facility in Palo Alto, CA in exchange for $21.0 million. The remaining $16.0 million is due when we fully surrender the facility in the third quarter of fiscal year 2010. Excluding the first surrender payment, cash used for investing activities decreased ~~$4.1~~$12.9 million in the first ~~quarter~~six months of fiscal year 2010 compared to the same period in the prior year primarily due to ~~reduced~~lower capital spending levels, as we have completed the majority of our spending related to the construction of our IRD facility in Walnut ~~Creek, partially offset by $1.3 million of cash paid in connection with the acquisition of certain net assets of Analogix, Inc. (the “Analogix Business”).~~Creek.

We generated ~~$1.6~~$3.3 million of cash from financing activities in the first ~~quarter~~six months of fiscal year 2010, which compares to ~~$0.5~~$5.5 million ~~generated by~~used for financing activities in the first ~~quarter~~six months of fiscal year 2009. Cash ~~generated~~flows from financing activities in the first ~~quarter~~six months of fiscal year 2010 ~~was higher~~improved due to higher stock option exercise ~~volume.~~volume and lower expenditures to repurchase and retire common stock.

We maintain relationships with banks in many countries from whom we sometimes obtain bank guarantees and short-term standby letters of credit. These guarantees and letters of credit relate primarily to advance payments and deposits made to our subsidiaries by customers for which separate liabilities are recorded in the unaudited condensed consolidated financial statements. As of ~~January 1,~~April 2, 2010, a total of ~~$13.8~~$12.2 million of these bank guarantees and letters of credit were outstanding. No amounts had been drawn by beneficiaries under these or any other outstanding guarantees or letters of credit as of that date.

As of both ~~January 1,~~April 2, 2010 and October 2, 2009, we had an $18.8 million term loan outstanding with a U.S. financial institution at a fixed interest rate of 6.7%. The term loan contains certain covenants that limit future borrowings and the payment of cash dividends and require the maintenance of certain levels of working capital and operating results. We were in compliance with all restrictive covenants of the term loan agreement at ~~January 1,~~April 2, 2010.

As of ~~January 1,~~April 2, 2010, we had several outstanding contingent consideration arrangements relating to acquired businesses. Amounts subject to these arrangements can be earned over ~~the~~their respective measurement ~~period,~~periods, depending on the performance of the acquired business relative to certain financial or operational targets.

The following table summarizes contingent consideration arrangements as of ~~January 1,~~April 2, 2010:

We also have an outstanding contingent consideration arrangement related to the purchase of certain assets. Remaining maximum contingent amounts under this arrangement were $2.6 million as of ~~January 1,~~April 2, 2010.

During the first quarter of fiscal year 2010, we made a cash payment of $1.3 million which was accrued as part of the purchase price to secure the seller’s indemnification obligations in connection with the acquisition of the Analogix Business in fiscal year 2007.

The Distribution Agreement with VMS provides that we are responsible for certain litigation to which VAI was a party, and further provides that we will indemnify VMS and VSEA for one-third of the costs, expenses and other liabilities relating to certain discontinued, former and corporate operations of VAI, including certain environmental liabilities (see Note 13 of the Notes to the Unaudited Condensed Consolidated Financial Statements).

We had no material cancelable or non-cancelable commitments for capital expenditures as of ~~January 1,~~April 2, 2010. In the aggregate, we currently anticipate that our capital expenditures will be less than 2.0% of sales for fiscal year 2010.

In February 2008, our Board of Directors approved a stock repurchase program under which we are authorized to utilize up to $100 million to repurchase shares of our common stock. During the first ~~quarter~~six months of fiscal year 2010, we did not purchase any shares under this authorization. This repurchase program expired on December 31, 2009.

Our liquidity is affected by many other factors, including on-going operations of our business, the pending acquisition by Agilent and external economic conditions. Our liquidity has not been materially affected by the pending acquisition ~~the deterioration in the global financial markets~~ or global economic conditions in general. However, current financial and economic conditions could adversely impact the availability of credit to us as well as to our customers and suppliers.

We have no material exposure to market risk for changes in interest rates or investment valuations. Our outstanding debt carries a fixed interest rate, and we invest our excess cash primarily in depository accounts and money market funds at various financial institutions. While we have not historically needed to borrow to support working capital or capital expenditure requirements, there is no assurance that we might not need to borrow to support these requirements ~~given~~depending on global economic conditions and whether such financing would be available.

We ~~nonetheless~~ believe that cash generated from operations, together with our current cash and cash equivalents balances and current borrowing capability, will be sufficient to satisfy our cash requirements for the next 12 months. There can be no assurance, however, that our business will continue to generate cash flows at current levels or that credit will be available to us if and when needed. Future operating performance and our ability to obtain credit will be subject to future economic conditions as well as financial, business and other factors, including the affects of the pendency of the acquisition by Agilent.

The following table summarizes the amount and estimated timing of future cash expenditures relating to principal and interest payments on outstanding long-term debt, minimum rentals due for certain facilities and other leased assets under long-term, non-cancelable operating leases and other long-term liabilities as of ~~January 1,~~April 2, 2010:


	Nine Months Ending Oct. 1, 2010		Fiscal Years												Total		Six Months Ending Oct. 1,		Fiscal Years
	Nine Months Ending Oct. 1, 2010		2011		2012		2013		2014		2015		Thereafter		Total		2010		2011		2012		2013		2014		2015		Thereafter		Total
(in thousands)
Operating leases	$	5,061	$	5,741	$	3,347	$	2,312	$	1,730	$	1,460	$	595	$	20,246	$	3,198	$	6,053	$	3,727	$	2,503	$	1,734		1,393	$	568	$	19,176
Long-term debt (including current portion)		6,250		—		6,250		—		6,250		—		—		18,750		6,250		—		6,250		—		6,250		—		—		18,750
Interest on long-term debt		838		838		733		419		314		—		—		3,142		523		838		733		419		314		—		—		2,827
Other long-term liabilities		—		5,592		3,550		2,929		2,805		2,593		25,511		42,980		—		6,301		3,431		2,941		2,694		2,557		24,011		41,935

Total	$	12,149	$	12,171	$	13,880	$	5,660	$	11,099	$	4,053	$	26,106	$	85,118	$	9,971	$	13,192	$	14,141	$	5,863	$	10,992	$	3,950	$	24,579	$	82,688

As of ~~January 1,~~April 2, 2010, we did not have any off-balance sheet commercial commitments that could result in a significant cash outflow upon the occurrence of some contingent event, except for contingent payments of up to a maximum of ~~$10.1~~$6.3 million related to acquisitions and $2.6 million related to the purchase of certain assets as discussed underLiquidity and Capital Resources above, the specific amounts of which are not currently determinable.

In December 2008, the FASB issued additional disclosure requirements for plan assets of a defined benefit pension or other postretirement plan. The required disclosures include a description of ~~the Company’s~~our investment policies and strategies, the fair value of each major category of plan assets, the inputs and valuation techniques used to measure the fair value of plan assets, the effect of fair value measurements using significant unobservable inputs on changes in plan assets and the significant concentrations of risk within plan assets. These additional disclosures are effective for annual disclosure for fiscal years ending after December 15, 2009. We do not expect the adoption of the new disclosure requirements in fiscal year 2010 to have a material impact on our financial condition or results of operations.

In October 2009, the FASB issued two new accounting standards that provide guidance for revenue recognition. The first standard revises guidance for arrangements with multiple deliverables. This accounting standard replaces the term fair value in the revenue recognition allocation guidance with selling price and establishes a hierarchy for determining the selling price of a deliverable. The selling price of each deliverable will first be based on vendor specific objective evidence (“VSOE”) if available, second on third-party evidence (“TPE”) if VSOE is not available and third on estimated selling price if neither VSOE nor TPE is available. In addition, the residual method is no longer permitted as vendors are now required to allocate arrangement consideration using the relative selling price method. The second new accounting standard excludes from the scope of software revenue recognition, software components contained in, and essential to the functionality of, tangible products. These two new accounting standards require expanded qualitative and quantitative disclosures and are effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption is permitted. We do not expect the adoption of these accounting standards in the first quarter of fiscal year 2011 to have a material impact on our financial condition or results of operations.

disclosures about postretirement benefit plan assets. These additional disclosures are effective for interim and annual reporting periods beginning after December 15, 2009. We do not expect our adoption of this accounting standard update in the second quarter of fiscal year 2010 to have a material impact on our financial condition or results of operations.

Foreign Currency Exchange Risk. We enter into foreign exchange forward contracts to minimize the short-term impact of foreign currency fluctuations on assets and liabilities denominated in non-functional currencies. From time to time, we also enter into foreign exchange forward contracts to minimize the impact of foreign currency fluctuations on forecasted transactions. The success of our hedging activities depends on our ability to forecast balance sheet exposures and transaction activity in various foreign currencies. To the extent that these forecasts are overstated or understated during periods of currency volatility, we ~~could~~would experience unanticipated currency gains or losses. However, we believe that in most cases ~~any such~~ gains or losses on balance sheet exposures would be substantially offset by losses or gains from the related foreign exchange forward contracts. Therefore, we believe that the direct effect of an immediate 10% change in the exchange rate between the U.S. dollar and all other currencies is not reasonably likely to have a material adverse effect on our financial condition or results of operations.

During the first ~~quarter~~six months of fiscal year 2010, we were not party to any foreign exchange forward contracts designated as cash flow hedges of forecasted transactions.

Our foreign exchange forward contracts generally do not extend beyond one month in original maturity. A summary of all foreign exchange forward contracts that were outstanding as of ~~January 1,~~April 2, 2010 follows:


	Notional Value Sold		Notional Value Purchased		Notional Value Sold		Notional Value Purchased
(in thousands)
Australian dollar	$	—	$	34,219	$	—	$	32,649
British pound		—		13,514		—		18,879
Euro		—		10,573		—		9,841
Japanese yen		5,688		—		6,505		—
Canadian dollar						3,201		—
Swedish krona						2,851		—
Brazilian real						2,042		—
Taiwan dollar						1,956		—
Singapore dollar						1,768		—
Korean won		2,558		—		1,322		—
Taiwan dollar		1,861		—
Canadian dollar		1,507		—
Singapore dollar		1,173		—

Total	$	12,787	$	58,306	$	19,645	$	61,369

Interest Rate Risk. We have no material exposure to market risk for changes in interest rates. We invest any excess cash primarily in depository accounts and money market funds, and changes in interest rates would not be material to our financial condition or results of operations. We enter into debt obligations principally to support general corporate purposes, including working capital requirements, capital expenditures and acquisitions. At ~~January 1,~~April 2, 2010, our debt obligations had fixed interest rates.

Based upon rates currently available to us for debt with similar terms and remaining maturities, the carrying ~~amounts~~amount of long-term debt ~~approximate their~~approximates its estimated fair ~~values.~~value. Although payments under certain of our operating leases for our facilities are tied to market indices, we are not exposed to material interest rate risk associated with our operating leases.

Principal Amounts and Related Weighted-Average Interest Rates By Year of Maturity


	Nine Months Ending Oct. 1, 2010			Fiscal Years																		Total			Six Months Ending Oct. 1,			Fiscal Years
	Nine Months Ending Oct. 1, 2010			2011			2012			2013			2014			2015			Thereafter			Total			2010			2011			2012			2013			2014			2015			Thereafter			Total
(in thousands)
Long-term debt (including current portion)	$	6,250		$	—		$	6,250		$	—		$	6,250		$	—		$	—		$	18,750		$	6,250		$	—		$	6,250		$	—		$	6,250		$	—		$	—		$	18,750
Average interest rate		6.7	%		—	%		6.7	%		—	%		6.7	%		—	%		—	%		6.7	%		6.7	%		—	%		6.7	%		—	%		6.7	%		—	%		—	%		6.7	%

Defined Benefit Retirement Plans. Most of our retirement plans, including all U.S.-based plans, are defined contribution plans. However, we also provide defined benefit pension plans in certain countries outside of the U.S. Our obligations under these defined benefit plans will ultimately be settled in the future and are therefore subject to estimation. Defined benefit pension accounting under FASB Accounting Standard Codification (“ASC”) 715-30,Defined Benefit Plans-Pension, is intended to reflect the recognition of future benefit costs over the employees’ estimated service periods based on the terms of the pension plans and our investment and funding decisions.

For our defined benefit pension plans, we make assumptions regarding several variables including the expected long-term rate of return on plan assets and the discount rate in order to determine defined benefit pension plan expense for the year. This expense is referred to as “net periodic pension cost.” We assess the expected long-term rate of return on plan assets and discount rate assumption for each defined benefit plan based on relevant market conditions and make adjustments to the assumptions as appropriate. On an annual basis, we analyze the rates of return on plan assets and discount rates used and determine that these rates are reasonable. For rates of return, this analysis is based on a review of the nature of the underlying assets, the allocation of those assets and their historical performance and expectations relative to relevant markets in the countries where the related plans are effective. Historically, our assumed asset allocations have not varied significantly from the actual allocations. Discount rates are based on the prevailing market long-term interest rates in the countries where the related plans are effective. As of October 2, 2009, the estimated long-term rate of return on our defined benefit pension plan assets ranged from 0.3% to 6.5% (weighted-average of 5.1%), and the assumed discount rate for our defined benefit pension plan obligations ranged from 1.8% to 5.6% (weighted-average of 5.4%).

If any of these assumptions were to change, our net periodic pension cost would also change. We incurred net periodic pension cost relating to our defined benefit pension plans of $1.4 million in fiscal year 2009, $1.5 million in fiscal year 2008 and $2.3 million in fiscal year 2007, and expect our net periodic pension cost to be approximately $1.2 million in fiscal year 2010. A 100 basis point decrease in the weighted-average estimated return on plan assets or assumed discount rate would increase our net periodic pension cost for fiscal year 2010 by $0.4 million or $0.5 million, respectively. As of October 2, 2009, our projected benefit obligation relating to defined benefit pension plans was $50.6 million. A 100 basis point decrease in the weighted-average estimated discount rate would increase this obligation by $10.3 million.

Disclosure Controls and Procedures. Based on the evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, our Chief Executive Officer and the Chief Financial Officer have concluded that as of the end of the period covered by this Quarterly Report on Form 10-Q ~~(for the period ended January 1,~~(April 2, 2010), our disclosure controls and procedures were effective.

Inherent Limitations on the Effectiveness of Controls. The Company’s management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent all error and all fraud. A control system, no matter how well designed and operated, can only provide reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons or by collusion of two or more people. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control over Financial Reporting. There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the ~~first~~second quarter of our fiscal year 2010 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

See Part I, Item 3—Legal Proceedings in Amendment No. 1 on Form 10-K/A for the fiscal year ended October 2, 2009, which Amendment was filed with the SEC on January 29, 2010.

See Item 1A—Risk Factors presented in our Annual Report on Form 10-K for the fiscal year ended October 2, 2009, which we encourage you to carefully consider.

(c) During the fiscal quarter ended ~~January 1,~~April 2, 2010, the Company repurchased and retired ~~4,000~~13,000 shares tendered to it by employees in settlement of employee tax withholding obligations due from those employees upon the vesting of restricted stock.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Delaware		77-0501995
(State or Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)

3120 Hansen Way, Palo Alto, California		94304-1030
(Address of Principal Executive Offices)		(Zip Code)


Large accelerated filer x		Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)		Smaller reporting company ¨


		Page
PART I	Financial Information

Item 1.	Financial Statements:

	Unaudited Condensed Consolidated Statement of Earnings	3

	Unaudited Condensed Consolidated Balance Sheet	4

	Unaudited Condensed Consolidated Statement of Cash Flows	5

	Notes to the Unaudited Condensed Consolidated Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2019

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

Item 4.	Controls and Procedures	2930

PART II	Other Information

Item 1.	Legal Proceedings	31

Item 1A.	Risk Factors	31

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31

Item 6.	Exhibits	31


Acquired Company/Business	Remaining Amount Available (maximum)		Measurement Period	Measurement Period End Date
	(in millions	)
Oxford Diffraction Limited	$ ~~7.0~~4.0		3 years	April 2011
Analogix Business	~~2.8~~2.0		3 years	December 2010
Other	0.3		~~2 years~~1 year	July 2010

Total	$~~10.1~~ 6.3


	January 1, 2010
	Gross		Accumulated Amortization			Net
(in thousands)
Intangible assets
Existing technology	$	16,275	$	(12,292	)	$	3,983
Patents and core technology		38,444		(18,379	)		20,065
Trade names and trademarks		2,474		(2,156	)		318
Customer lists		13,014		(11,339	)		1,675
Other		3,196		(2,677	)		519

Total	$	73,403	$	(46,843	)	$	26,560


	October 2, 2009
	Gross		Accumulated Amortization			Net
(in thousands)
Intangible assets
Existing technology	$	16,244	$	(11,738	)	$	4,506
Patents and core technology		38,515		(17,349	)		21,166
Trade names and trademarks		2,400		(2,120	)		280
Customer lists		12,996		(11,173	)		1,823
Other		3,227		(2,668	)		559

Total	$	73,382	$	(45,048	)	$	28,334


	April 2, 2010
	Gross		Accumulated Amortization			Net
	Gross		Accumulated Amortization			Net
(in thousands)
Intangible assets
Existing technology	$	16,132	$	(12,763	)	$	3,369
Patents and core technology		37,408		(18,929	)		18,479
Trade names and trademarks		2,460		(2,185	)		275
Customer lists		12,936		(11,435	)		1,501
Other		3,094		(2,630	)		464

Total	$	72,030	$	(47,942)		$	24,088


	October 2, 2009
	Gross		Accumulated Amortization			Net
	Gross		Accumulated Amortization			Net
(in thousands)
Intangible assets
Existing technology	$	16,244	$	(11,738	)	$	4,506
Patents and core technology		38,515		(17,349	)		21,166
Trade names and trademarks		2,400		(2,120	)		280
Customer lists		12,996		(11,173	)		1,823
Other		3,227		(2,668	)		559

Total	$	73,382	$	(45,048)		$	28,334


Total expense since inception of plans
	Restructuring Expense		Other Restructuring- related Costs (1)
(in millions)
Fiscal Year 2009 Second Quarter Plan	$	6.1	$	1.1
Fiscal Year 2009 First Quarter Plan		1.4		0.1
Fiscal Year 2007 Plan		2.9		8.7
Fiscal Year 2005 Plan		1.8		0.7

Total	$	12.2	$	10.6


Restructuring Plan		Estimated Annual Cost Savings
Fiscal Year 2007 Plan (Scientific Instruments - to combine and optimize the development and assembly on certain products and to centralize functions and reallocate resources to rapidly growing product lines)		$3 million - $5 million
Fiscal Year 2009 First Quarter Plan (Scientific Instruments - to reduce headcount and operating costs and increase operating margins)		$2 million - $3 million
Fiscal Year 2009 Second Quarter Plan (Scientific Instruments and Vacuum Technologies - to reduce ~~its~~ cost structure, primarily through headcount reduction)		$20 million - $24 million


		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	Date	Exhibit Number	Filed Herewith

10.1*	Retention and Incentive Agreement, dated as of January 27, 2010, between Varian, Inc. and Gordon Tredger.				X

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.				X

31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.				X

32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002).

32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002).

VARIAN, INC.
(Registrant)

Date: ~~February 5,~~May 12, 2010

/S/ G. EDWARD MCCLAMMY

G. Edward McClammy
Senior Vice President and Chief Financial Officer
(Duly Authorized Officer and
Principal Financial Officer)